Sep 10, 2026 04:57AM
Sep 4, 2026 06:00AM
Sep 3, 2026 07:30PM
Sep 1, 2026 07:30AM
Sep 1, 2026 07:30AM
Aug 5, 2026 08:00AM
Aug 3, 2026 04:01PM Stoke Therapeutics Announces Second Quarter 2026 Financial Results and Provides Business Updates
Jul 27, 2026 04:01PM
Jul 13, 2026 07:30AM
Jul 13, 2026 07:30AM
Jun 30, 2026 08:01AM
Jun 30, 2026 08:00AM
May 28, 2026 04:01PM
May 7, 2026 04:01PM Stoke Therapeutics Announces First Quarter 2026 Financial Results and Provides Business Updates
Apr 30, 2026 04:01PM
Apr 8, 2026 04:01PM
Apr 8, 2026 09:15AM
Apr 7, 2026 04:01PM
Apr 7, 2026 04:01PM
Mar 20, 2026 06:58AM
Mar 4, 2026 05:05PM The New England Journal of Medicine Publishes First Data to Demonstrate the Potential for Disease Modification in Dravet Syndrome
Feb 24, 2026 04:01PM
Feb 11, 2026 07:30AM
Feb 11, 2026 07:30AM
Feb 4, 2026 04:01PM
Jan 12, 2026 07:45AM
Jan 11, 2026 02:00PM
Jan 11, 2026 02:00PM Stoke Therapeutics Announces Updates to Timelines for the Completion of Enrollment and a Phase 3 Data Readout from the EMPEROR Study of Zorevunersen for the Treatment of Dravet Syndrome
Jan 5, 2026 04:34AM
Dec 5, 2025 09:01AM
Dec 5, 2025 09:00AM
Dec 5, 2025 09:00AM
Dec 1, 2025 07:31AM
Dec 1, 2025 07:30AM
Nov 4, 2025 04:01PM Stoke Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Updates
Oct 20, 2025 07:30AM
Oct 13, 2025 01:34PM
Oct 9, 2025 04:31PM
Oct 9, 2025 04:30PM
Oct 9, 2025 04:30PM
Sep 2, 2025 07:03AM
Sep 2, 2025 07:01AM Stoke Therapeutics and Biogen present 3-year zorevunersen data for Dravet
Sep 2, 2025 07:00AM
Sep 2, 2025 07:00AM
Aug 25, 2025 07:00AM
Aug 25, 2025 07:00AM
Aug 25, 2025 07:00AM
Aug 18, 2025 05:11AM
Aug 12, 2025 04:01PM Stoke Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Updates
Aug 11, 2025 07:00AM

330,678 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All